evidence_text: Senator Huizenga offered the following amendments:
  
  1. Amend page 344, following line 12, by inserting:
  
  “PFAS testing pilot project 5,000,000”.
  
  2. Amend page 344, line 19, after “$” by striking out “244,506,900” and inserting “249,506,900”.
  
  3. Amend page 345, line 10, after “$” by striking out “104,953,100” and inserting “109,953,100” and adjusting the subtotals, totals, and section 201 accordingly.
  
  4. Amend page 511, following line 2, by inserting:
  
  “Sec. 1958. (1) From the funds in part 1 for PFAS testing pilot project, the department shall appropriate $5,000,000.00 to establish and administer a grant program to provide 1 or more grants to a research institution to conduct a pilot project to assess the level of PFAS in the blood of and study the effects of PFAS on qualified study participants in this state.
  
  (2) The pilot project must be conducted in qualified counties. To be considered a qualified county a county must be one of the following:
  
  (a) A county with a population of more than 260,000 and less than 265,000 according to the most recent federal decennial census,
  
  (b) A county with a population of more than 650,000 and less than 675,000 according to the most recent federal decennial census, or
  
  (c) A county with a population of more than 295,000 and less than 300,000 according to the most recent federal decennial census.
  
  (3) Qualified study participants must be individuals who, on or after January 1, 2012 met 1 or more of the following conditions:
  
  (a) While under 11 years of age, resided in a qualified county in a household that used water from a well.
  
  (b) While under 11 years of age, resided in a qualified county in a household that used water from a public water supply with a PFAS level exceeding the public health drinking water screening levels for PFAS as set fort in the report dated February 22, 2019, published by the human health workgroup led by the department.
  
  (4) To be awarded a grant to conduct the pilot project described in this section, a research institution shall comply with all of the following:
  
  (a) Provide the department with a detailed summary of the proposed pilot project, including the goals and objectives of the proposed pilot project and a full explanation of the proposed pilot project and how the project will be conducted.
  
  (b) Demonstrate all of the following to the department:
  
  ( i ) That the research institution conducts research and studies related to public health.
  
  ( ii ) That the research institution is considered an R1 doctoral university by the Carnegie Classification of Institutions of Higher Education, indicating very high research activity at the research institution.
  
  ( iii ) That the proposed pilot project is approved by the applicable institutional review board of the research institution.
  
  (c) Agree to comply with all of the following as a condition of receiving a grant under this section for the pilot project:
  
  ( i ) That the research institution will obtain the informed consent of a qualified study participant or, if the qualified study participant is a minor, the informed consent of the parent, guardian, or person in loco parentis of the qualified study participant, to participate in the pilot project. The consent required under this subparagraph must inform the qualified study participant, or if the qualified study participant is a minor, the parent, guardian, or person in loco parentis of the qualified study participant, that the department and the research institution may only retain and use the data collected from a blood sample analyzed under this part for research under the pilot project with the consent of the qualified study participant or, if the qualified study participant is a minor, the consent of the parent, guardian, or person in loco parentis of the qualified study participant.
  
  ( ii ) That the research institution will require the qualified study participant to use a hospital reference laboratory to collect blood for a full blood panel test to ensure that a sufficient sample of blood is obtained by a qualified study participant for PFAS testing.
  
  ( iii ) That the research institution will require the hospital reference laboratory to send the specimen described in subparagraph ( ii ) to a state testing laboratory for analysis.
  
  ( iv ) That the research institution will coordinate with the department on the operation of the pilot project.
  
  (5) It is the intent of the legislature that the pilot project described in this section be continued for 5 years after the date an eligible research institution is selected by the department under this section.
  
  (6) The department shall do both of the following:
  
  (a) It is the intent of the legislature that beginning December 31, 2027 and by July 1 of each year thereafter, the department shall submit a report on the pilot project to the standard report recipients and the standing committees in the senate and house of representatives with jurisdiction over issues pertaining to public health. The report must include, but is not limited to, the number of subjects tested, and the number of grants awarded to the eligible research institution.
  
  (b) It is the intent of the legislature that, upon the conclusion of the pilot project, the department shall submit a report to the standard report recipients and the standing committees in the senate and house of representatives with jurisdiction over issues pertaining to public health. The report must summarize the impact and effectiveness of the pilot program and include any recommendations on PFAS-related legislation.
  
  (7) Funds appropriated for PFAS testing pilot project are considered work project funds, do not lapse at the end of the fiscal year, and are available for expenditures for projects under this section until the projects have been completed. The following is in compliance with section 451a of the management and budget act, 1984 PA 431, MCL 18.1451a:
  
  (a) The purpose of the work project is to establish and administer a grant program to provide 1 or more grants to a research institution to conduct a pilot project to assess the level of PFAS in the blood of and study the effects of PFAS on qualified study participants in this state.
  
  (b) The work project will be accomplished through partnerships with qualified counties.
  
  (c) The total estimated cost of the work project is $5,000,000.00.
  
  (d) The tentative completion date for the work project is September 30, 2031.”.
  
  The amendments were not adopted, a majority of the members serving not voting therefor.